B.J.Healthcare


Glimibose-VM 2/0.2 Tablets


Glimibose-VM 2/0.2 Tablets

Specifications

Composition Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)

INTRODUCTION

  • Glimibose-VM2 Tablet ER belongs to a category of medicines known as anti-diabetic drugs. It is a combination of medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
  • Glimibose-VM2 Tablet ER should be taken with food. Take it regularly at the same time each day to get the most benefit. Your doctor will decide what dose is best for you and this may change from time to time according to how it is working according to your blood sugar levels.
  • Keep taking this medicine, even if you feel well or your blood sugar levels are controlled. If you stop it without consulting your doctor, your blood sugar levels could rise and put you at risk of kidney damage, blindness, nerve problems and loss of limbs. Remember that it is only part of a treatment program that should also include a healthy diet, regular exercise, and weight reduction as advised by your doctor. Your lifestyle plays a big part in controlling diabetes.
  • The most common side effect of Glimibose-VM1 Tablet ER is low blood glucose levels (hypoglycemia). Make sure you recognize the signs of having low blood glucose levels, such as sweating, dizziness, headache, and shaking and know how to deal with it. To prevent this, it's important to have regular meals and always carry a fast-acting source of glucose such as sugary food or fruit juice with you. Drinking alcohol can also increase your risk of low blood sugar levels and should be avoided. Other side effects that may be seen on taking this medicine include taste changes, nausea, diarrhoea, stomach pain, headache, oedema (swelling), blurred vision, bone fracture, and upper respiratory tract infection. Some people may find that they put on weight with this medicine.
  • You should not take it if you have type 1 diabetes mellitus, if you have diabetic ketoacidosis (high levels of acid in your blood), or if you have severe kidney or liver disease. Before taking this medicine, tell your doctor if you have ever had heart disease. It may not be suitable. Pregnant or breastfeeding women should also consult their doctor before taking it. Your blood sugar levels should be checked regularly and your doctor may also advise blood tests to monitor your blood cell counts and liver function.

 

USES OF GLIMIBOSE-VM2 TABLET ER

Type 2 diabetes mellitus

 

SIDE EFFECTS OF GLIMIBOSE-VM2 TABLET ER

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

 

Common side effects of GLIMIBOSE-VM2

  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea
  • Taste change
  • Flatulence
  • Stomach pain
  • Headache
  • Skin rash
  • Respiratory tract infection

 

HOW TO COPE WITH SIDE EFFECTS?

The occurrence of side effects varies from person to person. The following are a few ways of dealing with some of the common side effects. However, consult your doctor if these persist.

 

Coping with Nausea

You can help yourself by eating small, frequent meals rather than large ones and drinking plenty of fluids. Eat slowly. Avoid fatty, fried, spicy and very sweet foods. Eat cold or slightly warm food if the smell of cooked or cooking food makes you feel sick. Get plenty of fresh air. You could also try chewing ginger or drinking ginger tea. Eat bananas to replace potassium in your blood which can drop if you are sick (vomit). Use oral rehydration salts to replace vitamins and minerals lost through being sick. There are some medicines that can help you stop from feeling sick. Speak to your doctor if your condition does not improve.

 

HOW TO USE GLIMIBOSE-VM2 TABLET ER

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Glimibose-VM2 Tablet ER is to be taken with food.

 

HOW GLIMIBOSE-VM2 TABLET ER WORKS

Glimibose-VM2 Tablet ER is a combination of three antidiabetic medicines: Glimepiride, metformin and voglibose. They work by different mechanisms to provide better control of blood sugar when single or dual therapy is not effective. Glimepiride is a sulfonylurea which works by increasing the amount of insulin released by the pancreas to lower the blood glucose. Metformin is a biguanide which lowers glucose production in the liver, delays glucose absorption from intestines and increases the body's sensitivity to insulin. Voglibose is an alpha-glucosidase inhibitor which prevents breakdown of complex sugars into simple sugars such as glucose. This prevents the blood glucose levels from rising to very high levels after meals.

 

SAFETY ADVICE

Alcohol

It is unsafe to consume alcohol with Glimibose-VM2 Tablet ER.

 

Pregnancy

Glimibose-VM2 Tablet ER may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.

 

Breastfeeding

Glimibose-VM2 Tablet ER is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.

 

Driving

Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.

 

Kidney

  • Glimibose-VM2 Tablet ER should be used with caution in patients with kidney disease. Dose adjustment of Glimibose-VM2 Tablet ER may be needed. Please consult your doctor.
  • Use of Glimibose-VM2 Tablet ER is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.

 

Liver

  • Glimibose-VM2 Tablet ER should be used with caution in patients with liver disease. Dose adjustment of Glimibose-VM2 Tablet ER may be needed. Please consult your doctor.
  • Glimibose-VM2 Tablet ER is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.

Yes! I am interested



  • Explore More Products




Looking for "Glimibose-VM 2/0.2 Tablets" ?